This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Efficacy and Safety of AP Collagen Peptide on the Skin

Sponsored by Amorepacific Corporation

About this trial

Last updated 4 years ago

Study ID

PNK-20D21-FF1R

Status

Completed

Type

Interventional

Phase

N/A

Placebo

Yes

Accepting

18-75 Years
35 to 60 Years
All
All

Trial Timing

Ended 4 years ago

What is this trial about?

This double-blinded, randomized, placebo-controlled study aimed to evaluate the efficacy and safety of AP collagen peptides (APCP) containing 3% Glycine-Proline-Hydroxyproline (GPH) on improving skin health. Subjects with dried skin were randomly assigned to receive placebo or APCP once daily for 12 weeks.

What are the participation requirements?

Yes

Inclusion Criteria

- Those whose eye wrinkles are Grade 3 or higher in the visual evaluation

- Those whose moisture retention in both cheeks measured by Corneometer® is 49 A.U. or less

- A person who has agreed to participate in this human application test before the start of the human application test and filled out the Informed Consent Form

No

Exclusion Criteria

- Those with skin diseases such as atopic dermatitis and psoriasis

- Those who are sensitive to or allergic to the food ingredients for this trial foods

- Those with skin abnormalities such as spots, acne, erythema, and hypersensitive skin at the test site

- People who take diet pills (absorbent and antidepressants, appetite suppressants, etc.) and contraceptives or hormones or diuretics within one month based on visit1

- Those who have used functional cosmetics for wrinkle improvement, highly moisturizing cosmetics, or skincare devices within 2 weeks of visit 1

- A person who used steroid-containing outer skin for more than one month to treat skin diseases

- A person who has received chemical and physical treatment (pattern, epidermis, lasers, procedures, etc.) in the test area within six months prior to the start of the test

- Visit 1 A person who has participated in other interventional clinical tests (including human application tests) within one month of the standard or plans to participate in other interventional clinical tests (including human application tests) after the start of this human application test

- A person who judges that the tester is inappropriate for this test

Locations

Location

Status